Endometriosis is a chronic, inflammatory gynecological condition in which tissue similar to the uterine lining (endometrium) grows outside the uterus. These abnormal growths—known as endometrial lesions, are commonly found on the ovaries, fallopian tubes, pelvic peritoneum, and outer surface of the uterus, and in severe cases, beyond the pelvic cavity.
Endometrial lesions respond to hormonal fluctuations during the menstrual cycle, leading to cyclical bleeding, inflammation, and pain. Common symptoms include chronic pelvic pain, painful menstruation (dysmenorrhea), pain during intercourse, fatigue, and infertility. These symptoms can significantly affect quality of life, mental health, work productivity, and reproductive outcomes, making long-term disease management essential.
According to BIS Research, the endometriosis market was valued $2.3 billion in 2023 and estimated to grow significantly during 2025–2035.
• Rising Awareness and Diagnosis Rates
• Advances in Diagnostic Technologies
• Shift Toward Targeted and Precision Therapies
• Growing Focus on Fertility Preservation
• Side Effects of Existing Hormonal Therapies
• High Cost of Advanced Treatments
• Limited Non-Hormonal Options
• Lack of Non-Invasive Diagnostics
Explore the Full TOC and Download Report Sample >>
The endometriosis market represents a critical opportunity within women’s health, driven by unmet clinical needs and growing recognition of the disease’s long-term impact. Innovation in diagnostics, targeted therapeutics, and patient-centered treatment strategies will define the competitive landscape and unlock sustained growth over the coming decade.
-BIS Research Analyst Team
Endometriosis is a chronic condition where uterine-like tissue grows outside the uterus.
Pelvic pain, painful periods, inflammation, and infertility are common symptoms.
About 10% of women of reproductive age worldwide are affected.
Its symptoms overlap with conditions like IBS and pelvic inflammatory disease.
BIS Research offers KOL-based insights, rigorous segmentation, and strategic advisory across software, hardware, and sensing tech domains.
